05/13/2025
3:42 PM | Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:54 PM | Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:34 PM | Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:57 PM | Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:01 PM | Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:03 PM | Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:10 PM | Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:53 PM | Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:56 PM | Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:17 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
3:29 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AMRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/02/2025
5:18 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
3:12 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:16 PM | Amneal Pharmaceuticals (Filer)
| Form DEFA14A | |
03/17/2025
3:45 PM | Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Filed by)
| Form SCHEDULE 13D/A | |
03/14/2025
6:32 PM | Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:11 PM | Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:16 PM | Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:17 PM | Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:17 PM | Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:18 PM | Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:18 PM | Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:21 PM | Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:53 PM | Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:31 PM | Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:33 PM | Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:11 PM | Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:12 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
9:00 AM | Amneal Pharmaceuticals (Subject)
Konidaris Tasos (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:03 PM | Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:58 PM | Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:59 PM | Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:13 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
7:59 AM | Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
3:31 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:49 PM | Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
| Form SCHEDULE 13D/A | |
01/15/2025
5:14 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:25 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:22 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:48 PM | Amneal Pharmaceuticals (Subject)
Patel Gautam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:41 PM | Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The DOJ Just Said Your Money Isn’t Yours (Ad) What If Washington Declared That:
YOUR Money ISN'T Actually Yours?
Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property.
What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want. Get your free guide now by clicking here >> |
11/25/2024
3:26 PM | Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:38 PM | Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
9:39 AM | Amneal Pharmaceuticals (Subject)
Kiely John (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
1:01 PM | Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
12:49 PM | Amneal Pharmaceuticals (Subject)
Daly Jason B. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
5:08 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
5:51 PM | Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
| Form SC 13D/A | |
10/30/2024
10:04 AM | Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
| Form SCHEDULE 13G | |
10/01/2024
6:10 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
2:12 PM | Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
10:04 AM | Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:27 PM | Amneal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
5:14 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy AMRX Stock Free AMRX Stock Alerts